Clinical trial
Impact of Routine Lymphadenectomy on Prognosis of Patients Undergoing Curative Resection for Intrahepatic Cholangiocarcinoma
NCT03796819 is registered in ClinicalTrials.gov with First Affiliated Hospital Xi'an Jiaotong University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Impact of Routine Lymphadenectomy on Prognosis of Patients Undergoing Curative Resection for Intrahepatic Cholangiocarcinoma
- Lead sponsor
- First Affiliated Hospital Xi'an Jiaotong University
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- January 10, 2019
- Completion date
- December 1, 2021
- Enrollment
- 260 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
intrahepatic cholangiocarcinoma